Plain-English translation of NCT05291819 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Psoriatic arthritis is a condition that causes inflammation in joints, tendons, and skin—but much of that inflammation can't be seen during a regular doctor's exam. This trial is testing whether using ultrasound and MRI scans to detect hidden inflammation and guide treatment decisions leads to better outcomes than the standard approach of relying mainly on what a doctor can see and feel during an exam.
Doctors currently treat psoriatic arthritis based on what they can observe clinically, but imaging like ultrasound and MRI can reveal inflammation that isn't obvious on physical examination. This trial is asking whether using these imaging tools to guide treatment could help more patients achieve sustained remission and better quality of life.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups: one receives standard treatment guided by clinical exams alone, and the other receives treatment guided by both clinical exams and ultrasound imaging (at every visit) plus MRI scans of the spine and sacroiliac joints (at the start and at 1 year). All participants receive the same medications based on current treatment guidelines. You would visit the clinic at regular intervals over 24 months and be assessed for remission (very low disease activity) at months 16, 20, and 24.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Norway